Biotech & Pharma

Flu Virus Interaction with Host Cell Machinery Mapped Inside Infected Cells

26 sec read0 views0 listens

Researchers at EMBL Hamburg and the Leibniz Research Institute for Molecular Pharmacology have mapped how influenza A virus interacts with human cells in unprecedented detail using a novel experimental workflow. This breakthrough provides insights into viral strategies and potential therapeutic targets, crucial for developing better drug therapies and vaccines against seasonal flu, which annually kills up to 650,000 people globally.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Nvidia Unveils Science Reasoning AI Suite with BioNeMo Agent Toolkit

Nvidia has launched the NVIDIA BioNeMo Agent Toolkit, an AI suite designed to automate complex scientific workflows in biotech and pharma. This toolkit leverages Nvidia’s microservices and tools to accelerate tasks such as protein structure predictio...

Ali Nemati

Biotech & PharmaJun 2132 sec read

StockWatch: Positive Phase III Data Sells Investors on Intellia

Intellia Therapeutics' lead CRISPR therapy lonvoguran ziclumeran met three key secondary endpoints in Phase III trials for hereditary angioedema, with 62% of patients achieving sustained attack-free status versus 11% on placebo. The one-time gene-edi...

Ali Nemati

Biotech & PharmaJun 1628 sec read

Pancreatic Cancer Cell Death Triggered by Caspase‑8 Blockade in Preclinical Models

Researchers at the University of Cologne’s Center for Molecular Medicine Cologne discovered that blocking caspase-8 can trigger cell death in KRAS-mutant pancreatic tumors, a common type of pancreatic cancer. This finding is significant because it id...

Ali Nemati

Biotech & PharmaJun 1524 sec read

ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs

ZoBio has launched a comprehensive DNA-Encoded Library (DEL) discovery service to aid in the identification of drug targets that are difficult or novel. This integrated platform combines multiple techniques, including protein production, biophysical ...

Ali Nemati

Biotech & PharmaJun 1230 sec read

Hantavirus One-Shot mRNA Vaccine Fully Protects in Syrian Hamster Model

Researchers at the University of Texas Medical Branch have developed a single-dose mRNA vaccine that provides full protection against the lethal Andes hantavirus in animal models. This breakthrough is critical for biotechnology professionals as it va...

Ali Nemati

Flu Virus Interaction with Host Cell Machinery Mapped Inside Infected Cells

Related Articles

Nvidia Unveils Science Reasoning AI Suite with BioNeMo Agent Toolkit

StockWatch: Positive Phase III Data Sells Investors on Intellia

Pancreatic Cancer Cell Death Triggered by Caspase‑8 Blockade in Preclinical Models

ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs

Hantavirus One-Shot mRNA Vaccine Fully Protects in Syrian Hamster Model